Azzadin A - Search Results

1

A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.

Malyszko J, Malyszko JS, Borawski J, Rydzewski A, Kalinowski M, Azzadin A, Mysliwiec M, Buczko W. Malyszko J, et al. Among authors: azzadin a. Thromb Res. 1995 Jan 15;77(2):133-43. doi: 10.1016/0049-3848(95)91619-v. Thromb Res. 1995. PMID: 7740505 Clinical Trial.

2

DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients.

Malyszko J, Malyszko JS, Azzadin A, Mysliwiec M, Buczko W. Malyszko J, et al. Among authors: azzadin a. Thromb Res. 1992 Nov 1;68(3):303-8. doi: 10.1016/0049-3848(92)90087-q. Thromb Res. 1992. PMID: 1471076 No abstract available.

3

Serotonin is involved in some effects of erythropoietin.

Azzadin A, Bialkowska A, Pawlak D, Chabielska E, Mazerska M, Mysliwiec M, Buczko W. Azzadin A, et al. Thromb Res. 1992 Mar 1;65(4-5):657-61. doi: 10.1016/0049-3848(92)90215-v. Thromb Res. 1992. PMID: 1615501 No abstract available.

4

Effects of verapamil on some parameters of haemostasis in rats with experimental chronic renal failure.

Azzadin A, Pietraszek MH, Buczko W. Azzadin A, et al. Thromb Res. 1990 Oct 1;60(1):99-103. doi: 10.1016/0049-3848(90)90344-c. Thromb Res. 1990. PMID: 2177575 No abstract available.

5

Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats.

Azzadin A, Mysliwiec J, Wollny T, Mysliwiec M, Buczko W. Azzadin A, et al. Thromb Res. 1995 Feb 1;77(3):217-24. doi: 10.1016/0049-3848(95)91609-o. Thromb Res. 1995. PMID: 7740514

6

Serotonergic mechanisms are involved in the hemostatic action of erythropoietin in uremic patients.

Malyszko J, Mazerska M, Malyszko J, Pawlak K, Azzadin A, Mysliwiec M, Buczko W. Malyszko J, et al. Among authors: azzadin a. Int J Clin Lab Res. 1993;23(1):42-4. doi: 10.1007/BF02592280. Int J Clin Lab Res. 1993. PMID: 8477092

7

The effect of tacrolimus (FK506) and cyclosporin A (CyA) on peripheral serotonergic mechanisms in uremic rats.

Mysliwiec J, Azzadin A, Chabielska E, Takada A, Mysliwiec M, Buczko W. Mysliwiec J, et al. Among authors: azzadin a. Thromb Res. 1996 Jul 15;83(2):175-81. doi: 10.1016/0049-3848(96)00118-1. Thromb Res. 1996. PMID: 8837316

8

Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment.

Borawski J, Rydzewski A, Pawlak K, Azzadin A, Buczko W, Mysliwiec M. Borawski J, et al. Among authors: azzadin a. Thromb Res. 1998 May 15;90(4):171-80. doi: 10.1016/s0049-3848(98)00031-0. Thromb Res. 1998. PMID: 9692616 Clinical Trial.

9

Platelet serotonergic mechanisms in patients with cancer of the urinary bladder.

Pawlak D, Malczyk E, Darewicz J, Azzadin A, Buczko W. Pawlak D, et al. Among authors: azzadin a. Thromb Res. 2000 Jun 1;98(5):367-74. doi: 10.1016/s0049-3848(00)00198-5. Thromb Res. 2000. PMID: 10828476

10

[Platelet aggregation during the recombinant human erythropoietin (rHuEPO) treatment of patients with uremia].

Mazerska M, Pawlak K, Azzadin A, Małyszko J, Małyszko J, Myśliwiec M, Buczko W. Mazerska M, et al. Among authors: azzadin a. Pol Arch Med Wewn. 1992 Oct;88(4):230-7. Pol Arch Med Wewn. 1992. PMID: 1488323 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters